Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Hsu David, Director. Officer active across 2 companies, notably MedMen Enterprises, Inc.. In total, 3 reports have been recorded. History available since 9 December 2021. The latest transaction was disclosed on 15 June 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations
Hsu David serves as a Board Member at MedMen Enterprises, Inc. In this role, he contributes to the governance of the company and strategic decision-making. His expertise in the cannabis business sector allows him to provide valuable insights during board discussions.